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ABSTRACT 
Objective: Paraplegia is a dangerous complication of thoracoabdominal aortic 
surgery. Various studies have been conducted on the prevention of this complication 
and some spinal cord protection methods have been proposed. However, there is 
not any modality that prevent the development of paraplegia certainly. In the I / R 
period, primary injury triggers secondary injury due to increased inflammation, 
apoptosis and free radical formation. In this study, we evaluated that the 
neuroprotective effect of adalimumab in spinal cord ischemia-reperfusion injury.  
Materials and Methods: In total, 24 adult New Zealand rabbits were divided into 
three groups: Group 1, control; Group 2, ischemia-reperfusion by infrarenal aortic 
clamping; Group 3, adalimumab treated followed by ischemia. Tissue and plasma 
tumor necrosis factor alpha, interleukin 6, interleukin 10, thiobarbituric acid reactive 
substance, total oxidant status and total antioxidant status levels were analyzed as a 
marker of inflammation and oxidation. Histopathological evaluation of the tissues 
was performed, and apoptosis was evaluated by TUNNEL method. 
Results: I/R injury significantly increases plasma and spinal cord tissue at TNF alpha, 
TOS, TBARS, IL6 levels and reduces plasma and spinal cord tissue to TAS and IL10 
levels. Adalimumab treatment significantly reduces plasma and spinal cord tissue to 
TNF alpha, TOS, TBARS, IL6 and increases plasma and tissue to TAS and IL10 levels.  
Conclusion: Adalimumab treatment significantly reduces the spinal cord neuronal 
damage score and the number of apoptotic cells. This paper aims to demonstrate the 
important neuroprotective effects of adalimumab on rabbit spinal cord I/R injury. 
 
 
1. INTRODUCTION 
Spinal cord reperfusion injury is described as cell death of neurons 
although improvement of blood supply of spinal cord after ischemia. It 
usually occurs because of oxygen free radical-induced lipid peroxida- 
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tio, leukocyte activation, inflammation and neuronal 
apoptosis. Although many clinical treatments of 
spinal cord injury have been provided in recent 
years, the results are far from satisfactory [1]. 
Paraplegia is a serious complication that can occur in 
a patient undergoing thoracoabdominal aortic 
surgery and has been seen in 2.4-40% of the patients 
[2]. Factors that cause this complication are: 
impaired arterial blood flow and I/R injury of the 
spinal cord due to collateral supplier damage, 
perfusion insufficiency, prolonged aortic cross-
clamping time, intraoperative proximal 
hypertension, high cerebrospinal fluid (CSF) pressure 
and postoperative hypotension [3]. Neurological 
injury that occurs after impact is called primary 
injury. Primary injury triggers secondary injury with 
increased inflammation, apoptosis and the 
formation of free radicals that have serious effects 
on outcome. Various pharmacological agents have 
been used to prevent secondary damage at different 
success rates [4]. However, there is no complete 
treatment of secondary injuries. 
Tumor necrosis factor is an important 
immunoregulator molecule that act important role in 
central nervous system events such as stroke [5]. 
There are two type of TNF molecule. First type of TNF 
molecule is transmembrane TNF which acts through 
cell-to-cell contact to initiate juxtracrine signaling and 
is important not only for cellular transmission in the 
natural immune system but also for functional 
improvement and axonal preservation [6,7]. The 
second type of TNF molecule is soluble TNF that acts 
in a paracrine manner and is a substantial mediator 
of both acute and chronic inflammation [8]. 
Adalimumab is a potent TNF alpha blocker.  It 
suppresses TNF-α and IL-6, initiate to reduction or 
inhibition of the inflammatory process [9]. Many 
studies have shown that TNF-α and IL-6 are elevated 
during I/R and that they are responsible for 
activation of the cell death by apoptosis [10]. 
Recently, the neuroprotective impacts of anti-TNF 
treatment have been studied in a model of focal 
cerebral ischemia and beneficial effects have been 
stated [11]. 
The aim of this study was to investigate the 
neuroprotective impacts of adalimumab on rabbit 
spinal cord I/R injury model. 
 
2. MATERIALS AND METHODS 
This research was carried out in the Experimental 
Medicine Application and Research Center of 
Necmettin Erbakan University. The experimental 
protocol was assessed and confirmed by the Ethics 
Review Committee of Necmettin Erbakan University. 
The animals were kept at a room temperature (18–
21 ºC) and fed on a standard diet. A 12 -h light–dark 
cycle (08:00 –20:00 hours light/20:01–07:59 hours 
dark) was preserved. The animals were able to get as 
much food and water as they wanted. 
 
2.1 Groups  
Twenty-four adult New Zealand rabbits were 
randomly separated into three groups: Group 1, 
control group (n=8); Group 2, ischemia-reperfusion 
(I/R) group and group 3 (n=8), I/R injury+ adalimumab 
(40 mg/kg, ip, single dose) treatment group.  
All rabbits were anesthetized by intramuscular (i. 
m.) injection of ketamine (50 mg/kg) (Ketalar, Parke-
Davis, Eczacıbaşı, Istanbul, Turkey) and xylazine (10 
mg/kg) (Rompun, Bayer, Istanbul, Turkey) and 
permitted to breathe during the procedure. An 
intravenous catheter was placed in the auricular vein 
of the animals and preoperative cefazolin 10 mg/kg 
(Cefamezin, Eczacıbası, Istanbul, Turkey) was given as 
a single dose. As maintenance, 0.9% NaCl (20 ml/h) 
was given throughout the experiment. 
All rabbits underwent laparotomy in supine 
position. Aortic cross-clamp was not applied to group 
1. In group 2 and 3 the abdominal aorta was detected 
and dissected carefully from the beginning of the left 
renal artery by transperitoneal approach. Five 
minutes before occlusion, 100 IU/ kg heparin was 
given intravenously. The aorta was then cross-
clamped using an aneurysm clip with a closing force 
of 70 grams (Yasargil FE 721, Aesculap). The clipping 
site was just below the origin of the left renal artery. 
Pulsation of the femoral artery disappeared after 
occlusion. The aneurysm clip was removed 30 
minutes later, and aortic pulsation was restored. 
Neither aortic nor caval hemorrhage were observed 
during surgery. Before closure, rabbits of group 3 
received single dose intraperitoneal 40 mg/kg 
adalimumab treatment. After the closure of 
laparotomy all rabbits awoke and returned to their 
cages. The animals were followed neurologically, and 
motor inefficiency and recovery rates were recorded. 
Seventy-two hours later, all rabbits were re-
anesthetized by intramuscular (i. m.) injection of 
ketamine (50 mg/kg) (Ketalar, Parke-Davis, 
Eczacıbaşı, Istanbul, Turkey) and xylazine (10 mg/kg) 
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(Rompun, Bayer, Istanbul, Turkey). Blood samples 
were taken from auricular veins for biochemical 
examination. For histopathological examination 
spinal cord samples were taken from lumbar spinal 
cord segments between L4-L6 by laminectomies and 
the rabbits were sacrificed.  
 
2.2 Biochemical Analysis 
Venous blood samples were collected by 
centrifugation at 4° C and 1,000 g for 10 minutes to 
remove plasma. Plasma samples were kept at -80 ° C 
until the parameters were studied.  
Spinal cord tissue samples were provided in pH 
7.4 50 mM phosphate buffer and kept at -80 ° C until 
they were analyzed. The thawed tissue samples were 
weighed and homogenized in ice using a mechanical 
homogenizer and an ultrasonic homogenizer in a 
10fold (w / v) cold phosphate buffer (50 mM, pH: 7.4). 
The supernatants were separated by centrifuging the 
homogenates for 10 min at 4 ° C and 10.000 g. Pierce 
bicinchoninic acid-BCA (Thermo Scientific, Illinois, 
USA) was used to measure spectrophotometrically 
plasma and spinal cord tissue total oxidant (TOS) and 
antioxidant status (TAS) (Rel Assay Diagnostics, 
Gaziantep, Turkey), thiobarbituric acid reactive 
substances (TBARS) (Oxford Biomedical Research, 
Missouri, USA) and tissue protein levels. Plasma and 
spinal cord tissue IL-6, IL-10 and TNF alpha levels 
were examined by using ELISA antigens that were 
intrinsic to rabbits (Elabscience Biotechnology Co., 
Wuhan, China).  
 
2.3 Histopathological Studies 
Spinal cord samples were stabilized by 10% 
formaldehyde for two days and then embedded in 
paraffin blocks. After dehydration, coronal sections 
of the spinal cord segment were severed at a 
thickness of 4 μm and stained with hematoxylin and 
eosin (HE) in order to examine the structural 
changes. Gray matter was checked in five different 
areas in each section. Depending on the degree of 
inflammation, hemorrhage, axonal swelling, 
congestion, neuronal degeneration and 
vacuolization of the spinal cord, the light microscopic 
findings were graded on a scale ranging from 0 to 3, 
corresponding to “no change”, “mild”, “moderate” 
and “severe” changes, respectively. The 
histopathological score was calculated for each 
spinal cord sample [12]. 
Apoptotic cells were labeled using an ApopTag In 
Situ Apoptosis Detection Kit (Millipore). DNA 
fragments in spinal cord regions were altered by the 
action of terminal deoxynucleotidyl transferase. The 
manufacturer’s instructions were followed during 
procedures. In each section five dark visual fields 
were randomly chosen, and the TUNEL-positive 
neurons and the total number of neurons in the 
selective visual fields was counted. TUNEL-positive 
index (the TUNEL-positive to whole neurons ratio) 
was computed. Eight sections from each group were 
used for measurement, and five high-powered 
visuals were indiscriminately picked from every 
section to carry out measurement of the TUNEL-
positive indices [13]. 
 
2.4 Statistical analysis 
Data were analyzed using SPSS (version 24.0, SPSS 
Inc.) and expressed as mean ± SD. Comparisons 
were made by the Kruskal-Wallis test. Differences 
among the groups were evaluated by the Mann-
Whitney U test. A p < 0.05 was considered statistically 
significant. Histopathological score and TUNEL 
positive cell count were contrasted using a one-way 
analysis of variance (ANOVA) with TUKEY test. 
 
3. RESULTS 
3.1 Histopathological evaluation 
I/R injury significantly increased the spinal cord 
neuronal damage score and apoptotic cell count. 
Adalimumab treatment statistically substantially 
decreased spinal cord neuronal injury score and 
apoptotic cell count (p=0). Large motor cells were 
observed in anterior horn of the spinal cord in the 
control group (Figure 1A). No changes were observed 
in the neurons. The most serious injury was seen in 
ischemia-reperfusion group in spinal cord in HE 
sections (Figure 1B, C, D). Necrosis, hemorrhage and 
congestion were noticed in ischemia-reperfusion 
group. Nissl substances disappeared in necrotic 
neurons. In addition, neuropil vacuolization and 
tissue loss were observed in the gray matter (Figure 
1E, F, G). Compared with control group, it was noticed 
that histopathological score rose in ischemia-
reperfusion group. Histopathological alterations and 
score significantly reduced in adalimumab treatment 
group (Fig 1H). Myelin swelling determined in white 
matter in ischemia group and the adalimumab group 
had less myelin swelling compared to the ischemia 
group. (Figure 2A, B, C). TUNEL positive cells count 
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increased in I/R group when compared with control 
group (Figure 3A, B). Adalimumab treatment 
decreased TUNEL positive cells count (Figure 3C). Figure 3D showed 
differences among groups.  
 
 
Figure 1. Histopathological photomicrographs of spinal cord tissue stained HE A: Control Group : Neurons in grey matter and White 
matter B: Necrotic neurons in Ischemia-Reperfusion Group (black arrow), Haemorrhage ve (arrows), *:vacuoles. C:  chromatolyses 
in Ischemia-Reperfusion Group (arrow head), *:vacuoles. D: pyknosis in Ischemia-Reperfusion Group (arrows), necrotic neurons 
(arrows). E: Normal neurons in Adalimumab treatment group F: haemorrhage in Adalimumab treatment group (arrow). G: 
Congetion in Adalimumab treatment group (arows). H: Histopathological assessment of spinal cord, (* P < 0.05, compared to group 
1; &P < 0.05, compared to group 2). 
 258 Yasar Karatas, Mehmet Fatih Erdi, Bulent Kaya et al. 
 
Figure 2. Histopathological photomicrographs of white matter stained HE A: Control Group. B: Ischemia-Reperfusion Group C: 
Adalimumab treatment group. 
 
 
Figure 3. Representative spinal cord sections stained in the TUNEL assay. A: Control group, B:İschemia-Reperfusion group  C: 
Adalimumab treatment group .D: Comparison of groups according to TUNEL-positive cells in spinal cord, (* P < 0.05, compared to 
group 1; &P < 0.05, compared to group 2). 
 
3.2 Biochemical evaluation 
I/R injury significantly increased the plasma and 
spinal cord tissue TNF alpha, TOS, TBARS, IL6 levels 
and reduced the plasma and spinal cord tissue TAS 
and IL10 levels. Adalimumab treatment significantly 
decreased the plasma and spinal cord tissue TNF 
alpha, TOS, TBARS, IL6 levels and raised plasma and 
tissue TAS and IL10 levels (Figure 4, Figure 5).
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Figure 4. The effects of adalimumab on plasma levels of TAS,TOS,TBARS,TNF ALPHA,IL6,IL10. 
 
 
Figure 5. The effects of adalimumab on tissue levels of TAS,TOS,TBARS,TNF ALPHA,IL6,IL10. 
 
 
4. DISCUSSION 
Neural tissues can be said to be very sensitive to 
ischemia. I / R damage of the spinal cord during 
thoracoabdominal vascular surgery can cause 
serious discomfort such as paraplegia. Primary injury 
triggers secondary injury with increased 
inflammation, apoptosis and free radical formation 
during the I / R period [14]. Secondary injury may 
result in endothelial dysfunction and increase 
vascular permeability that promotes migration and 
activation of immune cells. These activated immune 
cells infiltrates the related area and secrete some 
proinflammatory cytokines. Enhanced inflammation 
causes reactive oxygen species produce and induces 
lipid peroxidation which causes injury in the 
ultrastructure of neural cell membranes and hinders 
their critical functions [15]. 
The spinal cord is very sensitive to ischemia 
because it has its own anatomical features. “The 
infrarenal aortic cross-clamp” method used in this 
study leads to severe spinal cord injury. It was first 
described by Liang et al. as an experimental method 
[16,17]. Rabbits have segmental blood supply in their 
lumbosacral spinal cord. Thus, rabbit model of spinal 
cord I/R injury is commonly used. It is clear that there 
are many causes of paraplegia. Long-term ischemia, 
interruption of critical intercostal and lumbar 
arteries, decrease in spinal cord perfusion pressure 
and postoperative reperfusion injury are some of 
these reasons [18]. Therefore, this method is 
thought to be appropriate to imitate the 
complications of aortic surgery. 
High levels of plasma and spinal cord tissue TNF 
alpha, TOS, TBARS and IL6 in I/R group signifies 
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increased inflammation and oxidative stress. 
Neuronal damage score and apoptotic cell count 
increase after I/R injury. Adalimumab treatment 
significantly improves biochemical and 
histopathological adverse impacts of I/R injury. 
 
5. CONCLUSION 
In this study, it was found that adalimumab had 
significant neuroprotective effects on rabbit spinal 
cord I/R injury. After I / R injury, high inflammation 
and oxidative stress were successfully reversed by 
adalimumab, and the worse effects of biochemical, 
histopathological and neurological I / R damage were 
mitigated. Further studies are needed to carry out 
this treatment in clinical practices. 
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